Oura CEO Tom Hale said the company is evolving into a complete health intelligence platform rather than remaining just a wearable company.
This transition signals a strategic pivot for the Finnish company as it seeks to integrate deeper data analytics into its ecosystem. By moving beyond hardware, Oura aims to compete more directly with comprehensive health-tech platforms that offer predictive wellness insights.
Speaking on CNBC's "Squawk Box" program, Hale said the company's growth trajectory and upcoming product offerings are evolving. He said the shift toward a broader platform approach is supported by a $900 million [1] funding round.
The funding comes as the company expands its product line, including the launch of the Oura Ring 5. The new model is described as the world's smallest smart ring, intended to capture more precise biometric data for the health intelligence system.
While the company focuses on its platform expansion, market analysts have noted the firm's potential for public trading. Some reports indicate a proposed IPO valuation of over €9 billion [2]. This valuation reflects the increasing investor interest in the intersection of consumer electronics and preventative healthcare.
Hale said the goal is to provide users with a more holistic view of their health. The company intends to use its new capital to accelerate the development of software, and services that translate raw wearable data into actionable health intelligence.
“We are not just a wearable company, we are a complete health intelligence platform”
Oura's shift from a hardware-centric model to a health intelligence platform mirrors a wider trend in the wearables industry where data monetization and software ecosystems provide more sustainable growth than device sales alone. By securing significant funding and targeting a high valuation, Oura is positioning itself as a medical-grade data provider rather than a simple fitness tracker, potentially altering how consumers and providers interact with preventative health data.
